Speciality: Physician (Internal Medicine)
Description:
A warm welcome to all the medical professionals in this interesting session on Growth Update - Turner Syndrome Practice Updates
Turner Syndrome (TS) is a chromosomal disorder affecting females, characterized by partial or complete loss of one X chromosome. Recent practice updates emphasize the importance of early diagnosis and intervention to optimize growth and development outcomes. Growth hormone (GH) therapy has become a cornerstone in managing short stature associated with TS, with evidence showing significant improvements in height when initiated at an early age. Regular monitoring and individualized dosing are critical to maximize the benefits of GH therapy while minimizing potential side effects.
Advancements in genetic testing have improved the accuracy and speed of diagnosing Turner Syndrome, allowing for earlier and more precise interventions. These updates also highlight the importance of a multidisciplinary approach in managing TS, addressing not only growth concerns but also associated comorbidities such as cardiovascular, renal, and reproductive health issues. Comprehensive care plans involving endocrinologists, cardiologists, nephrologists, and reproductive specialists are essential to provide holistic care for individuals with TS.
Therefore, get an overall knowledge of Growth Update - Turner Syndrome Practice Updates
See More Webinars @ Hidoc Webinars
1.
Advances in "next generation" photoactive cancer therapy
2.
Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL
3.
The American College of Physicians updated its recommendations for colorectal cancer screening.
4.
Optimizing Sequencing of BCMA-Directed Therapies in Myeloma
5.
According to a study, patients with ovarian cancer who undergo aggressive surgery have a 70% lower chance of dying.
1.
Quality of Life Using Precision Functional Recovery After Organ-Preserving Interventions
2.
Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis
3.
Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy
4.
Modern Developments in Oncology for Specialists
5.
Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
2.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
3.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
4.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
5.
Navigating the Complexities of Ph Negative ALL - Part XII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation